Society for Cardiovascular Angiography and Interventions

In this Healio video exclusive, J. Dawn Abbott, MD, FSCAI, and James B. Hermiller, MD, MSCAI, discuss the impactful research and highlights from the 2024 Society for Cardiovascular Angiography and Interventions Scientific Sessions.

Endovascular therapy with stent implantation confers similar outcomes and lower complication rates vs. vascular bypass surgery for symptomatic femoropopliteal peripheral artery disease, regardless of sex, a speaker reported.

Two catheter-directed thrombectomy devices demonstrated efficacy and safety in the treatment of acute intermediate-risk pulmonary embolism, speakers reported.

Despite significant decline in heart attacks since 2004, inequities in STEMI management and mortality by age, gender, income and race, speakers reported.

Use of radial access for PCI has increased greatly in the U.S. over the last decade and is associated with lower risk for mortality, bleeding and nonfatal vascular complications compared with a transfemoral approach, a speaker reported.

AI accurately predicted several measures of cardiac function from coronary angiography that would otherwise require additional tests such as echocardiography or catheterization, a speaker reported.

In a first-in-human study, a new class of transcatheter heart valve demonstrated good safety and restored aortic blood flow to levels similar to a healthy aortic valve at 1 year, a speaker reported.

Use of advanced thrombolysis in the U.S. remains low and is prone to disparate use among women and Black patients presenting with pulmonary embolism, a speaker reported.

Gene therapy improved exercise capacity and blood flow and reduced chest pain occurrence and nitroglycerine use for patients with advanced ischemic heart disease, a speaker reported.

Patients not required to fast before cardiac catheterization reported higher overall postprocedural satisfaction with no periprocedural adverse events, a speaker reported.